Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of Biomarkers for Predicting Immunotherapy Response in Hepatocellular Carcinoma

NCT04965454 is registered in ClinicalTrials.gov with Queen's Medical Center as lead sponsor.

NCT NCT04965454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04965454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of Biomarkers for Predicting Immunotherapy Response in Hepatocellular Carcinoma
Lead sponsor
Queen's Medical Center
Phase
Phase 2
Overall status
Recruiting
Start date
March 28, 2022
Completion date
June 30, 2028
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma non-resectable